Gentilini, G <br/><br/>
An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies.  [electronic resource] 

 -  Blood  Oct 1998 
 - 2359-65 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Animals<br/>Anti-Ulcer Agents--adverse effects<br/>Antibodies, Monoclonal--immunology<br/>Antibody Specificity<br/>Antigen-Antibody Reactions<br/>Autoantibodies--immunology<br/>Autoimmune Diseases--chemically induced<br/>Blood Platelets--immunology<br/>CHO Cells<br/>Cimetidine--chemistry<br/>Cricetinae<br/>Cricetulus<br/>Epitopes--immunology<br/>Famotidine--chemistry<br/>Female<br/>Flow Cytometry<br/>Histamine H2 Antagonists--adverse effects<br/>Humans<br/>Molecular Structure<br/>Nizatidine--chemistry<br/>Platelet Glycoprotein GPIb-IX Complex--chemistry<br/>Precipitin Tests<br/>Protein Conformation<br/>Quinidine--adverse effects<br/>Quinine--adverse effects<br/>Ranitidine--adverse effects<br/>Recombinant Fusion Proteins--immunology<br/>Structure-Activity Relationship<br/>Thrombocytopenia--chemically induced<br/>Transfection